197 related articles for article (PubMed ID: 11681761)
1. Integrated treatment of comorbid depression and substance use disorders.
Charney DA; Paraherakis AM; Gill KJ
J Clin Psychiatry; 2001 Sep; 62(9):672-7. PubMed ID: 11681761
[TBL] [Abstract][Full Text] [Related]
2. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
[TBL] [Abstract][Full Text] [Related]
3. The treatment of sedative-hypnotic dependence: evaluating clinical predictors of outcome.
Charney DA; Paraherakis AM; Gill KJ
J Clin Psychiatry; 2000 Mar; 61(3):190-5. PubMed ID: 10817104
[TBL] [Abstract][Full Text] [Related]
4. Recognition and management of depression in a substance use disorder treatment population.
Curran GM; Booth BM; Kirchner JE; Deneke DE
Am J Drug Alcohol Abuse; 2007; 33(4):563-9. PubMed ID: 17668342
[TBL] [Abstract][Full Text] [Related]
5. Clinical guidelines for the treatment of depressive disorders. VII. Comorbidity.
Enns MW; Swenson JR; McIntyre RS; Swinson RP; Kennedy SH;
Can J Psychiatry; 2001 Jun; 46 Suppl 1():77S-90S. PubMed ID: 11441774
[TBL] [Abstract][Full Text] [Related]
6. Improving the care for depression in patients with comorbid medical illness.
Koike AK; Unützer J; Wells KB
Am J Psychiatry; 2002 Oct; 159(10):1738-45. PubMed ID: 12359681
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders.
Brown C; Schulberg HC; Madonia MJ; Shear MK; Houck PR
Am J Psychiatry; 1996 Oct; 153(10):1293-300. PubMed ID: 8831437
[TBL] [Abstract][Full Text] [Related]
8. A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents.
Mufson L; Dorta KP; Wickramaratne P; Nomura Y; Olfson M; Weissman MM
Arch Gen Psychiatry; 2004 Jun; 61(6):577-84. PubMed ID: 15184237
[TBL] [Abstract][Full Text] [Related]
9. The impact of depression on the outcome of addictions treatment.
Charney DA; Paraherakis AM; Negrete JC; Gill KJ
J Subst Abuse Treat; 1998; 15(2):123-30. PubMed ID: 9561951
[TBL] [Abstract][Full Text] [Related]
10. Improving care for depression in patients with comorbid substance misuse.
Watkins KE; Paddock SM; Zhang L; Wells KB
Am J Psychiatry; 2006 Jan; 163(1):125-32. PubMed ID: 16390899
[TBL] [Abstract][Full Text] [Related]
11. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.
Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET
J Clin Psychiatry; 2002 Feb; 63(2):126-34. PubMed ID: 11874213
[TBL] [Abstract][Full Text] [Related]
12. Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacotherapy.
Carroll KM; Nich C; Rounsaville BJ
J Nerv Ment Dis; 1995 Apr; 183(4):251-9. PubMed ID: 7714514
[TBL] [Abstract][Full Text] [Related]
13. Clinical Outcomes From a 10-Week Follow-Up Psychoeducational Program for Dual Diagnosis.
Chilton J; Crone D; Tyson PJ
J Dual Diagn; 2018; 14(2):102-110. PubMed ID: 29461932
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of cognitive-behavioural therapy plus pharmacotherapy in inpatient treatment of depressive disorders.
Köhler S; Hoffmann S; Unger T; Steinacher B; Dierstein N; Fydrich T
Clin Psychol Psychother; 2013; 20(2):97-106. PubMed ID: 22095701
[TBL] [Abstract][Full Text] [Related]
15. Cognitive-behavioral group therapy for panic disorder in the general clinical setting: a naturalistic study with 1-year follow-up.
Martinsen EW; Olsen T; Tønset E; Nyland KE; Aarre TF
J Clin Psychiatry; 1998 Aug; 59(8):437-42; quiz 443. PubMed ID: 9721829
[TBL] [Abstract][Full Text] [Related]
16. Quality of Outpatient Depression Treatment in Patients With Comorbid Substance Use Disorder.
Coughlin LN; Pfeiffer P; Ganoczy D; Lin LA
Am J Psychiatry; 2021 May; 178(5):414-423. PubMed ID: 33115247
[TBL] [Abstract][Full Text] [Related]
17. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
[TBL] [Abstract][Full Text] [Related]
18. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
Lee JH; Dunner DL
Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
[TBL] [Abstract][Full Text] [Related]
19. Differential response to cognitive therapy in parolees with primary and secondary substance use disorders.
Nishith P; Mueser KT; Srsic CS; Beck AT
J Nerv Ment Dis; 1997 Dec; 185(12):763-6. PubMed ID: 9442189
[No Abstract] [Full Text] [Related]
20. Gender differences in depression: implications for treatment.
Kornstein SG
J Clin Psychiatry; 1997; 58 Suppl 15():12-8. PubMed ID: 9427872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
